MX362829B - Formas cristalinas de derivados de dihidropirimidina. - Google Patents
Formas cristalinas de derivados de dihidropirimidina.Info
- Publication number
- MX362829B MX362829B MX2015004115A MX2015004115A MX362829B MX 362829 B MX362829 B MX 362829B MX 2015004115 A MX2015004115 A MX 2015004115A MX 2015004115 A MX2015004115 A MX 2015004115A MX 362829 B MX362829 B MX 362829B
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- dihydropyrimidine derivatives
- infection
- dihydropyrimidine
- derivatives
- Prior art date
Links
- WCFAPJDPAPDDAQ-UHFFFAOYSA-N 1,2-dihydropyrimidine Chemical class C1NC=CC=N1 WCFAPJDPAPDDAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000002672 hepatitis B Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210369019 | 2012-09-27 | ||
| CN201310117076 | 2013-04-04 | ||
| PCT/CN2013/084383 WO2014048355A1 (en) | 2012-09-27 | 2013-09-27 | Crystalline forms of dihydropyrimidine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015004115A MX2015004115A (es) | 2016-01-20 |
| MX362829B true MX362829B (es) | 2019-02-14 |
Family
ID=50355923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015004115A MX362829B (es) | 2012-09-27 | 2013-09-27 | Formas cristalinas de derivados de dihidropirimidina. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9403814B2 (enExample) |
| EP (1) | EP2900664B1 (enExample) |
| JP (1) | JP6310923B2 (enExample) |
| KR (1) | KR20150060610A (enExample) |
| CN (3) | CN103724339B (enExample) |
| AU (1) | AU2013324779B2 (enExample) |
| BR (1) | BR112015002979B8 (enExample) |
| CA (1) | CA2881260C (enExample) |
| DK (1) | DK2900664T3 (enExample) |
| ES (1) | ES2660642T3 (enExample) |
| HU (1) | HUE037285T2 (enExample) |
| MX (1) | MX362829B (enExample) |
| MY (1) | MY171497A (enExample) |
| PL (1) | PL2900664T3 (enExample) |
| PT (1) | PT2900664T (enExample) |
| RU (1) | RU2646599C2 (enExample) |
| SG (1) | SG11201500145TA (enExample) |
| TW (1) | TWI561520B (enExample) |
| WO (1) | WO2014048355A1 (enExample) |
| ZA (1) | ZA201500290B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881322A1 (en) * | 2012-09-10 | 2014-03-13 | F. Hoffmann-La Roche Ag | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
| CA3004147C (en) * | 2015-11-04 | 2019-09-10 | Qilu Pharmaceutical Co., Ltd. | Crystal form, preparation method and intermediate of dihydropyrido ring compound |
| WO2017198201A1 (en) * | 2016-05-19 | 2017-11-23 | Sunshine Lake Pharma Co., Ltd. | Crystalline form, salt and complex of dihydropyrimidine derivative, and uses thereof in medicine |
| CN107722109B (zh) * | 2016-08-11 | 2020-12-18 | 广东东阳光药业有限公司 | 作为丙型肝炎病毒抑制剂的晶型 |
| US9856232B1 (en) * | 2017-06-20 | 2018-01-02 | King Saud University | Dihydropyrimidinone derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043880A1 (es) | 2003-04-22 | 2005-08-17 | Solvay Pharm Gmbh | Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas |
| WO2008154819A1 (fr) | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| PT2514750E (pt) * | 2007-06-18 | 2014-01-23 | Sunshine Lake Pharma Co Ltd | Tiazolil dihidropirimidinas substituídas com bromo-fenilo |
| CN101328170B (zh) | 2007-06-18 | 2011-09-14 | 张中能 | 一种氟苯基-取代噻唑二氢嘧啶 |
| WO2008154820A1 (fr) | 2007-06-18 | 2008-12-24 | Zhang, Zhongneng | Thiazolyl-dihydropyrimidines à substitution carbéthoxy |
| WO2010069147A1 (zh) * | 2008-12-17 | 2010-06-24 | 张中能 | 二氢嘧啶类化合物、其组合物及其应用 |
| CN101744823B (zh) * | 2008-12-17 | 2013-06-19 | 广东东阳光药业有限公司 | 一种二氢嘧啶类化合物的固体分散体及其药用制剂 |
-
2013
- 2013-09-26 CN CN201310446506.0A patent/CN103724339B/zh active Active
- 2013-09-26 TW TW102134813A patent/TWI561520B/zh active
- 2013-09-26 CN CN201310445326.0A patent/CN103694234A/zh active Pending
- 2013-09-26 CN CN201510364423.6A patent/CN104945394B/zh active Active
- 2013-09-27 HU HUE13841041A patent/HUE037285T2/hu unknown
- 2013-09-27 MY MYPI2015700253A patent/MY171497A/en unknown
- 2013-09-27 KR KR1020147037155A patent/KR20150060610A/ko not_active Ceased
- 2013-09-27 BR BR112015002979A patent/BR112015002979B8/pt active IP Right Grant
- 2013-09-27 PT PT138410410T patent/PT2900664T/pt unknown
- 2013-09-27 RU RU2015114085A patent/RU2646599C2/ru active
- 2013-09-27 ES ES13841041.0T patent/ES2660642T3/es active Active
- 2013-09-27 PL PL13841041T patent/PL2900664T3/pl unknown
- 2013-09-27 SG SG11201500145TA patent/SG11201500145TA/en unknown
- 2013-09-27 US US14/420,666 patent/US9403814B2/en active Active
- 2013-09-27 WO PCT/CN2013/084383 patent/WO2014048355A1/en not_active Ceased
- 2013-09-27 CA CA2881260A patent/CA2881260C/en active Active
- 2013-09-27 DK DK13841041.0T patent/DK2900664T3/en active
- 2013-09-27 EP EP13841041.0A patent/EP2900664B1/en active Active
- 2013-09-27 JP JP2015533438A patent/JP6310923B2/ja active Active
- 2013-09-27 MX MX2015004115A patent/MX362829B/es active IP Right Grant
- 2013-09-27 AU AU2013324779A patent/AU2013324779B2/en active Active
-
2015
- 2015-01-15 ZA ZA2015/00290A patent/ZA201500290B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| UA113956C2 (xx) | Похідні піримідину для лікування вірусних інфекцій | |
| PH12015501156A1 (en) | Pharmaceutical compositions | |
| PH12015500274A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| IN2015DN01156A (enExample) | ||
| MD20140135A2 (ro) | Inhibitori macrociclici ai viruşilor din familia Flaviviridae | |
| IN2015DN03327A (enExample) | ||
| MX2016004492A (es) | Inhibidores de la replicacion del virus de inmunodeficiencia humana (vih). | |
| NZ703040A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| MD4589B1 (ro) | Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C | |
| MY197723A (en) | Vaccine compositions for the prevention of dengue virus infection | |
| PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
| PH12015502230A1 (en) | Novel viral replication inhibitors | |
| MX363270B (es) | Composiciones y metodos para inhibir la polimerasa viral. | |
| IN2014MN01548A (enExample) | ||
| MX371093B (es) | Compuestos de microarn y metodos para modular al mir-122. | |
| PH12014500385A1 (en) | Benzofuran compounds for the treatment of hepatitis c virus infections | |
| WO2014152716A8 (en) | Substituted heterocyclic compounds for treating or preventing viral infections | |
| MY171497A (en) | Crystalline forms of dihydropyrimidine derivatives | |
| WO2014167582A3 (en) | Vaccine composition for prophylaxis in ruminants | |
| ZA201307019B (en) | Compositions for preventing and/or treating and infection by an hiv-1 virus | |
| IN2011CH03893A (enExample) | ||
| EA019080B9 (ru) | α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА | |
| MY169312A (en) | An antiviral pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |